Skip to main content
SearchLoginLogin or Signup

Reviews of "Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron"

Reviewers: Azam Roohi (Tehran University of Medical Sciences) | 📗📗📗📗◻️ • | 📘📘📘📘📘

Published onFeb 21, 2022
Reviews of "Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron"

To read the original manuscript, click the link above.

Summary of Reviews: This preprint examines the role of interferon-λ (IFN-L) in providing protection against COVID-19 using mouse model systems. Reviewers found the main claims of the paper reliable, with findings informative for future evaluation of IFN-L treatment’s efficacy in COVID-19 patients.

Reviewer 1 (Azam Roohi) | 📗📗📗📗◻️

Reviewer 2 | 📘📘📘📘📘

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below. 


Connections
1 of 2
A Supplement to this Pub
Description

This preprint examines the role of interferon-λ (IFN-L) in providing protection against COVID-19 using mouse model systems. Reviewers found the main claims of the paper reliable, with findings informative for future evaluation of IFN-L treatment’s efficacy in COVID-19 patients.

Comments
0
comment

No comments here

Why not start the discussion?